iSpecimen Inc
NASDAQ:ISPC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ovid Therapeutics Inc
NASDAQ:OVID
|
US |
|
Z
|
ZAZZ Energy of Sweden AB (publ)
STO:ZAZZ B
|
SE |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its Industry Average (16.1), the stock would be worth $-6.97 (4 251% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.4 | $0.17 |
0%
|
| Industry Average | 16.1 | $-6.97 |
-4 251%
|
| Country Average | 13.3 | $-5.79 |
-3 546%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
iSpecimen Inc
NASDAQ:ISPC
|
4.5m USD | -0.4 | -0.2 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 18.4 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
26.8B USD | 18 | 28 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.7B AUD | 115.3 | 62.8 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 15.6 | 20.2 | |
| SE |
|
Sectra AB
STO:SECT B
|
52.1B SEK | 65.2 | 97 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD | 14.7 | 40.6 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 13.6 | 17.9 | |
| US |
H
|
Heartflow Inc
NASDAQ:HTFL
|
2.8B USD | 0 | 0 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19B CNY | 37.9 | -61.5 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 64.1 | -328 |
Market Distribution
| Min | 0 |
| 30th Percentile | 8.8 |
| Median | 13.3 |
| 70th Percentile | 20.1 |
| Max | 3 188 432.5 |
Other Multiples
iSpecimen Inc
Glance View
iSpecimen, Inc. operates as healthcare organization that engages in procurement of human biospecimens. The company is headquartered in Lexington, Massachusetts and currently employs 59 full-time employees. The company went IPO on 2021-06-17. The firm designed iSpecimen Marketplace platform to transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. The Company’s marketplace platform ingests de-identified healthcare data provided by healthcare supply partners. The iSpecimen Marketplace supports the supply chain management and bioprocurement process for specimens and associated data. The Company’s platform helps with administrating and reporting function for researchers, suppliers, and internal personnel, including user and compliance management. The firm serves to biopharmaceutical companies, in vitro diagnostic (IVD) companies, and government/academic institutions.
